2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine (DOEF) is a psychedelic drug of the phenethylamine, amphetamine, and DOx families.[1][2][3]
- None
| |
| Clinical data | |
|---|---|
| Other names | DOEF; 2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine; 4-(2-Fluoroethyl)-2,5-dimethoxyamphetamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | 1–2 hours[1] Peak: 3 hours[1] |
| Duration of action | 12–16 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H20FNO2 |
| Molar mass | 241.306 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists DOEF's dose as 2 to 3.5 mg orally and its duration as 12 to 16 hours.[1] The drug's onset was 1 to 2 hours and peak effects occurred after 3 hours.[1] The effects of DOEF were reported to include unworldliness, closed-eye imagery no appreciable open-eye visuals or not highly visual, time dilation, music and erotic enhancement, no body discomfort, insomnia, and sleep disruption, among others.[1]
Interactions
Chemistry
History
DOEF was first described in the scientific literature by Alexander Shulgin and colleagues in 1988.[6] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.[1]
Society and culture
Legal status
DOEF is a controlled substance in Canada under phenethylamine blanket-ban language.[7]